Mersana Therapeutics, Inc. (MRSN)
$29.08+0.00%Close
BUYBULL · day 16
Key stats
- Market cap
- $145M
- Beta
- 0.43
- P/E (TTM)
- -4.56
- 1W
- +1.22%
- 1M
- +5.86%
- vs SPY 1W
- +0.06%
- vs SPY 1M
- +2.87%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on MRSN?
- LOPJLB’s latest quantitative signal on Mersana Therapeutics, Inc. (MRSN) is BUY in a BULL regime. Signals are updated daily.
- What market regime is MRSN in?
- Mersana Therapeutics, Inc. (MRSN) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Mersana Therapeutics, Inc. (MRSN) do?
- Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering novel antibody-drug conjugates (ADCs) for cancer patients with pressing unmet medical needs. Their flagship product candidate, XMT-1592, a Dolasynthen ADC engineered to target NaPi2b-expressing tumor cells, is presently undergoing Phase I clinical evaluation for the treatment of ovarian cancer and N…